The Latest
-
GT Medical raises $100M for brain tumor tech after clinical trial success
Adoption of the GammaTile radiotherapy implant is growing, the company said, and the new funding round validates its potential to be a standard of care treatment.
-
MiniMed is in the lead as diabetes tech firms focus on ‘fully closed loop’ systems, exec says
Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in developing automated insulin delivery systems that don’t require meal announcements.
-
Medtech M&A remains strong in 2026
Recent deals include Boston Scientific buying a $1.5 billion stake in MiRus and Medtronic agreeing to acquire SPR Therapeutics. Read MedTech Dive’s roundup of the top M&A deals so far this year.
Updated June 10, 2026 -
Bausch + Lomb to lay off employees in Missouri
The company plans to eliminate 119 positions by mid-December as part of a phased transfer of some production from the manufacturing site.
-
Medtronic set for Stealth AXiS expansion in Europe
With the CE mark for ear, nose and throat procedures, the advanced surgical navigation platform will be available to more surgeons across the region.
-
Medtronic gets FDA nod for updated pulse oximetry system
The changes support accuracy across diverse patient populations, skin tones and clinical care settings.
-
Dexcom bolsters evidence for glucose sensors for Type 2 diabetes
New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said.
-
Deep Dive
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.
Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.
-
3 takeaways from ADA
Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.
-
Boston Scientific to build Indiana distribution center
The planned logistics site, near a principal manufacturing facility, will handle global distribution of Boston Scientific’s medical devices.
-
Q&A
Olympus’ Keith Boettiger on robotic GI surgery push
Keith Boettiger, head of Olympus’ gastrointestinal solutions division, delves into the endoscopy leader’s endoluminal robotics strategy.
-
J&J, Medtronic back CereVasc’s $85M funding round
CereVasc is developing a minimally invasive treatment for the buildup of fluid in the brain.
-
Dexcom buys Nutrisense; Insulet rolls out patch pump update
In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet improved the software for its latest patch pump.
-
More Americans own wearables, connected health devices: survey
Many adults are sharing device data with their providers too. But users are typically healthier and wealthier, suggesting people who could benefit the most from monitoring are less likely to adopt the tools, according to Rock Health.
-
Medtronic seeks clearance for Hugo surgical robot in more indications
Securing 510(k) authorization would position Medtronic to compete with Intuitive in major robotic surgery markets.
-
Edwards gets FDA approval for surgical tricuspid valve
Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.
-
Medtronic boosts revenue by nearly double digits in Q4
Strength in cardiac ablation solutions, where the company picked up market share, helped Medtronic post its best annual revenue growth rate in a decade.
-
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.
-
At ASCO, Grail points to positive signals in MCED data
Grail executives were upbeat on study results for the Galleri multi-cancer early detection test, while ASCO said more evidence is needed before it is incorporated into screening guidelines.
-
Trump further tweaks steel, aluminum, copper tariffs
A greater range of industrial and agricultural equipment made with the metals will temporarily face a reduced 15% levy starting June 8, per the White House.
-
Resmed completes $340M Noctrix takeover
The buyout gives Resmed control of a noninvasive treatment for restless legs syndrome.
-
Q&A
Natera’s Solomon Moshkevich on how MRD testing pinpoints cancer recurrence
Molecular residual disease testing could one day be as ubiquitous as a CT scan, says Natera’s president of clinical diagnostics.
-
Intuitive elevates Taylor Patton to chief commercial and marketing officer
Patton’s promotion comes as competition in robotic surgery intensifies, and Intuitive looks to expand its global commercial operations to meet anticipated growth.
-
Court overturns Insulet’s $59M trade secret verdict against EOFlow
The U.S. appeals court ruled that Insulet filed the lawsuit too late, considering when it should have learned of the trade secret concerns.
-
California attorney general sues over 23andMe data breach
The attorney general said the civil penalties could add up to “multiple millions” if the suit is successful.